These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35582001)

  • 1. Rapid and ecofriendly UPLC quantification of Remdesivir, Favipiravir and Dexamethasone for accurate therapeutic drug monitoring in Covid-19 Patient's plasma.
    Emam AA; Abdelaleem EA; Abdelmomen EH; Abdelmoety RH; Abdelfatah RM
    Microchem J; 2022 Aug; 179():107580. PubMed ID: 35582001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel environment friendly TLC-densitometric method for the determination of anti-coronavirus drugs "Remdesivir and Favipiravir": Green assessment with application to pharmaceutical formulations and human plasma.
    Noureldeen DAM; Boushra JM; Lashien AS; Hakiem AFA; Attia TZ
    Microchem J; 2022 Mar; 174():107101. PubMed ID: 34955554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of UPLC method for simultaneous assay of some COVID-19 drugs utilizing novel instrumental standard addition and factorial design.
    El-Shorbagy HI; Mohamed MA; El-Gindy A; Hadad GM; Belal F
    Sci Rep; 2023 Apr; 13(1):5466. PubMed ID: 37016018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of two COVID-19 antiviral agents, favipiravir and remdesivir, in spiked human plasma using spectrophotometric methods; greenness evaluation.
    Batubara AS; Abdelazim AH; Almrasy AA; Gamal M; Ramzy S
    BMC Chem; 2023 Jun; 17(1):58. PubMed ID: 37328879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive and selective bioscreening of the most commonly used coronavirus disease drug, Favipiravir, and its co-administered therapeutic, Meropenem, in human plasma.
    Abdelfatah RM; Abdelaleem EA; Abdelmomen EH; Abdelmoety RH; Emam AA
    J Sep Sci; 2022 Oct; 45(20):3800-3810. PubMed ID: 35948316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eco-friendly spectrophotometric methods for determination of remdesivir and favipiravir; the recently approved antivirals for COVID-19 treatment.
    Elama HS; Zeid AM; Shalan SM; El-Shabrawy Y; Eid MI
    Spectrochim Acta A Mol Biomol Spectrosc; 2023 Feb; 287(Pt 2):122070. PubMed ID: 36403556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrofluorimetric determination of the anti-Covid 19 agent, remdesivir, in vials and spiked human plasma.
    Attia TZ; Boushra JM; Abdel Hakiem AF; Lashien AS; Noureldeen DAM
    Luminescence; 2022 Jul; 37(7):1192-1199. PubMed ID: 35548893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An ultrasensitive green synchronous factorized spectrofluorimetric approach for the simultaneous determination of Favipiravir and Molnupiravir: Application to pharmaceutical, environmental, and biological matrices.
    ElSherbiny MS; Eid SM; Kelani KM; Abdel Ghany MF; El-Olemy A; Hasan MA; Abbas MM
    Luminescence; 2024 Aug; 39(8):e4837. PubMed ID: 39113185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conventional and synchronous spectrofluorometric determination of the recently administered drugs for treatment of COVID-19 favipiravir and apixaban.
    Elama HS; Zeid AM; Shalan SM; El-Shabrawy Y; Eid MI
    Sci Rep; 2022 Dec; 12(1):21520. PubMed ID: 36513795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrofluorimetric quantitative analysis of favipiravir, remdesivir and hydroxychloroquine in spiked human plasma.
    Ramzy S; Abdelazim AH; Osman AO; Hasan MA
    Spectrochim Acta A Mol Biomol Spectrosc; 2022 Nov; 281():121625. PubMed ID: 35863184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental impact of the reported chromatographic methods for the determination of the first FDA-Approved therapy for COVID-19 Patients, Remdesivir: A comparative study.
    Ahmed AB; Gamal M; Naguib IA; Ali HM; Abdallah FF
    Microchem J; 2022 May; 176():107242. PubMed ID: 35125520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes in COVID-19 patients treated with antivirals: a retrospective analysis.
    Jain J; Chandak D; Basak S
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel, rapid and simple UPLC-MS/MS method for quantification of favipiravir in human plasma: Application to a bioequivalence study.
    Rezk MR; Badr KA; Abdel-Naby NS; Ayyad MM
    Biomed Chromatogr; 2021 Jul; 35(7):e5098. PubMed ID: 33606892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-COVID-19 drug Favipiravir: Degradation, Method development, Validation, NMR/LC-MS characterization, and
    Abdallah IA; El-Behairy MF; Ahmed RM; Fayed MAA
    Chem Zvesti; 2022; 76(10):6415-6426. PubMed ID: 35812721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC-MS/MS method in human serum.
    Habler K; Brügel M; Teupser D; Liebchen U; Scharf C; Schönermarck U; Vogeser M; Paal M
    J Pharm Biomed Anal; 2021 Mar; 196():113935. PubMed ID: 33548872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of plasma remdesivir and its metabolite GS-441524 using liquid chromatography coupled to tandem mass spectrometry. Application to a Covid-19 treated patient.
    Alvarez JC; Moine P; Etting I; Annane D; Larabi IA
    Clin Chem Lab Med; 2020 Aug; 58(9):1461-1468. PubMed ID: 32573468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A validated UHPLC-MS/MS method for simultaneous quantification of some repurposed COVID-19 drugs in rat plasma: Application to a pharmacokinetic study.
    El Azab NF
    Microchem J; 2022 Jul; 178():107321. PubMed ID: 35261396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eco-Friendly Synchronous Spectrofluorimetric Method for Simultaneous Determination of Remdesivir and Acetyl Salicylic Acid in Spiked Human Plasma.
    Aboelghar SM; Hegazy MA; Wagdy HA
    J Fluoresc; 2024 Aug; ():. PubMed ID: 39150458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Green and sensitive spectrofluorimetric determination of Remdesivir, an FDA approved SARS-CoV-2 candidate antiviral; application in pharmaceutical dosage forms and spiked human plasma.
    Elmansi H; Ibrahim AE; Mikhail IE; Belal F
    Anal Methods; 2021 Jun; 13(23):2596-2602. PubMed ID: 34019051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjusted green spectrophotometric determination of favipiravir and remdesivir in pharmaceutical form and spiked human plasma sample using different chemometric supported models.
    Imam MS; Abdelazim AH; Ramzy S; Batubara AS; Gamal M; Abdelhafiz S; Zeid AM
    BMC Chem; 2023 Jul; 17(1):89. PubMed ID: 37501208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.